Back to Search
VICTOR ALONSO, PH.D.
PH.D.
EEG Technician
NPI: 1134424849Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Focal acral hyperpigmentation in a patient undergoing chemotherapy with capecitabine.
PMID 19489659·Am J Clin Dermatol·2009
5-case
Sulfasalazine induced oxidative stress: a possible mechanism of male infertility.
PMID 19028562·Reprod Toxicol·2009
7-preclinical
Phytoestrogen modulation of bone-related cytokines and its impact on cell viability in human prostate cancer cells.
PMID 19632246·Life Sci·2009
8-other
Lipid peroxidation and antioxidant status in kidney and liver of rats treated with sulfasalazine.
PMID 19071188·Toxicology·2009
7-preclinical
Gene expression profile in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.
PMID 19026495·Cancer Detect Prev·2009
4-observational
Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study.
PMID 17957505·Acta Oncol·2008
3-trial
Fungi and selected mycotoxins from pre- and postfermented corn silage.
PMID 18005347·J Appl Microbiol·2008
8-other
Phase I/II study of gefitinib and capecitabine in patients with colorectal cancer.
PMID 18208793·Clin Transl Oncol·2008
3-trial
Receptor activator of nuclear factor-kappaB ligand (RANKL) as a novel prognostic marker in prostate carcinoma.
PMID 18366009·Histol Histopathol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 N SAM HOUSTON PKWY E, SUITE 156
HOUSTON, TX 77060 - Phone
- (713) 261-2950
Quick Facts
- NPI
- 1134424849
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile